Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 for Prevention of Interferon-Induced Depression in Hepatitis C
NCT00408304Phase 2Unknown
- Sponsor
- Bnai Zion Medical Center
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omega-3-acid triglycerides in major depressive disorder (MDD), sponsored by Bnai Zion Medical Center. Status: unknown.
02
Drugs
omega-3-acid triglycerides
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00408304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408304.